|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 188.24 USD | +1.82% |
|
+0.10% | +6.96% |
| 03-09 | Global drugmakers rush to boost US presence as tariff threat looms | RE |
| 03-06 | Health Rounds: Protein related to Parkinson's linked to faster Alzheimer's progression in women | RE |
| Capitalization | 27.63B 23.83B 21.52B 20.62B 37.48B 2,545B 39.19B 254B 102B 1,217B 104B 101B 4,369B | P/E ratio 2026 * |
15.9x | P/E ratio 2027 * | 15x |
|---|---|---|---|---|---|
| Enterprise value | 27.58B 23.79B 21.48B 20.59B 37.42B 2,541B 39.12B 254B 102B 1,215B 104B 101B 4,362B | EV / Sales 2026 * |
2.93x | EV / Sales 2027 * | 2.61x |
| Free-Float |
85.5% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biogen Inc.
| 1 day | +1.82% | ||
| 1 week | +0.10% | ||
| Current month | -1.87% | ||
| 1 month | -2.87% | ||
| 3 months | +7.05% | ||
| 6 months | +31.09% | ||
| Current year | +6.96% |
| 1 week | 181.24 |  | 190.99 |
| 1 month | 181.24 | | 200.29 |
| Current year | 160.36 | | 202.41 |
| 1 year | 110.04 | | 202.41 |
| 3 years | 110.04 | | 319.76 |
| 5 years | 110.04 | | 468.55 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 13/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 28/02/2025 |
Jane Grogan
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Caroline Dorsa
CHM | Chairman | 66 | 25/06/2023 |
Eric Rowinsky
BRD | Director/Board Member | 69 | 22/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 31/12/2009 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | 0.00% | 4.3% | 1 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.82% | +0.10% | +25.18% | -27.32% | 27.63B | |
| +2.86% | -1.16% | +10.47% | +5.09% | 80.21B | |
| +2.30% | +3.72% | +54.84% | +226.98% | 56.58B | |
| -3.95% | +57.90% | +57.90% | +57.90% | 49.5B | |
| +2.98% | -0.47% | -43.40% | -49.46% | 48.23B | |
| +6.13% | +5.48% | +56.53% | -59.42% | 22.01B | |
| +1.21% | -2.94% | +37.17% | +33.27% | 19.32B | |
| +4.95% | +7.18% | +120.00% | +120.85% | 18.14B | |
| +3.19% | +1.41% | +30.57% | +61.92% | 14.12B | |
| -1.74% | -10.06% | -0.54% | +900.00% | 13.27B | |
| Average | +1.98% | -1.40% | +34.87% | +126.98% | 34.9B | |
| Weighted average by Cap. | +1.80% | -1.32% | +28.58% | +78.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.42B 8.13B 7.34B 7.03B 12.78B 868B 13.36B 86.64B 34.74B 415B 35.36B 34.6B 1,490B | 9.35B 8.07B 7.29B 6.98B 12.69B 862B 13.27B 86.03B 34.5B 412B 35.12B 34.36B 1,479B |
| Net income | 1.86B 1.6B 1.45B 1.39B 2.52B 171B 2.64B 17.1B 6.86B 81.93B 6.98B 6.83B 294B | 2.01B 1.73B 1.57B 1.5B 2.73B 185B 2.85B 18.48B 7.41B 88.55B 7.54B 7.38B 318B |
| Net Debt | -46.71M -40.29M -36.38M -34.87M -63.37M -4.3B -66.26M -430M -172M -2.06B -175M -172M -7.39B | -3.26B -2.81B -2.54B -2.43B -4.42B -300B -4.62B -29.94B -12.01B -143B -12.22B -11.96B -515B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/03/26 | 188.24 $ | +1.82% | 651,626 |
| 06/03/26 | 184.87 $ | -1.71% | 772,906 |
| 05/03/26 | 188.08 $ | -0.98% | 893,331 |
| 04/03/26 | 189.94 $ | +3.22% | 952,927 |
| 03/03/26 | 184.02 $ | -2.14% | 1,049,925 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BIIB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition